TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: morphine consumption at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain scores at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quadriceps strength at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in global cognitive z-scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: tolerability of sunitinib and erlotinib combination
Endpoint domain: Adverse events/effects
Primary endpoint: maximum plasma concentration (Cmax) of erlotinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under plasma concentration-time profile of erlotinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain scores for cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spray discomfort scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient preference for analgesia spray
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percentage of patients needing alternative exploration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: standing long jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients meeting the primary endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proficiency change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete platelet response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Major platelet response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Venous Thromboembolism (VT) occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Deep venous thrombosis occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Combined death and disability score at 3 months after stroke
Endpoint domain: Mortality/survival
Primary endpoint: miss rate for polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: miss rate for adenomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SN iron levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of CVC-RBSI
Endpoint domain: Adverse events/effects
Primary endpoint: Functional decline measured by Disability Assessment for Dementia scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional decline measured by Dependence Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: activity of SOD and GSH‐px in serums
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes